This topic contains a solution. Click here to go to the answer

Author Question: If algae are oxygen-producing aquatic life, why does overproduction lead to a decrease in oxygen ... (Read 34 times)

fox

  • Hero Member
  • *****
  • Posts: 540
If algae are oxygen-producing aquatic life, why does overproduction lead to a decrease in oxygen content of the water?
 
  A) They consume more oxygen than they produce.
  B) They block the absorption of oxygen at the surface of the water.
  C) They block the light needed by photosynthetic aquatic life.
  D) none of the above
  E) both A and B

Question 2

Two isotopes of the same element differ only in the number of neutrons found in the nucleus.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

apple

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

E

Answer to Question 2

TRUE




fox

  • Member
  • Posts: 540
Reply 2 on: Aug 27, 2018
Wow, this really help


nyrave

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Throughout history, plants containing cardiac steroids have been used as heart drugs and as poisons (e.g., in arrows used in combat), emetics, and diuretics.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library